BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 4644642)

  • 21. Interpretation of plasma concentration-time curves after oral dosing.
    Ronfeld RA; Benet LZ
    J Pharm Sci; 1977 Feb; 66(2):178-80. PubMed ID: 839412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variation in biologic availability of digoxin from four preparations.
    Lindenbaum J; Mellow MH; Blackstone MO; Butler VP
    N Engl J Med; 1971 Dec; 285(24):1344-7. PubMed ID: 5121186
    [No Abstract]   [Full Text] [Related]  

  • 23. Route of administration and drug metabolism.
    Gibaldi M; Feldman S
    Eur J Pharmacol; 1972 Sep; 19(3):323-9. PubMed ID: 4640856
    [No Abstract]   [Full Text] [Related]  

  • 24. [Differences in drug pharmacokinetics and effects upon oral versus parenteral administration. Review with special interest in first-pass effect on the liver].
    Morland J
    Tidsskr Nor Laegeforen; 1976 Mar; 96(9-10):554-8. PubMed ID: 1258025
    [No Abstract]   [Full Text] [Related]  

  • 25. Shortcomings in pharmacokinetic analysis by conceiving the body to exhibit properties of a single compartment.
    Riegelman S; Loo JC; Rowland M
    J Pharm Sci; 1968 Jan; 57(1):117-23. PubMed ID: 5652110
    [No Abstract]   [Full Text] [Related]  

  • 26. [The consequence of the preparation factors for the effect of the drug].
    Johnsgård M; Pedersen AO
    Tidsskr Nor Laegeforen; 1973 Apr; 93(10):698-703. PubMed ID: 4755086
    [No Abstract]   [Full Text] [Related]  

  • 27. [Biologic availability and "1st pass" effect of drugs].
    Rietbrock N; Keller F
    Fortschr Med; 1977 Jul; 95(28):1765-6, 1774-80. PubMed ID: 914146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pharmacokinetic studies on H3-digoxin and H3-lanatosid in man].
    Dengler HJ; Bodem G; Wirth K
    Arzneimittelforschung; 1973 Jan; 23(1):64-74. PubMed ID: 4740698
    [No Abstract]   [Full Text] [Related]  

  • 29. Route of administration and drug disposition.
    Gibaldi M; Perrier D
    Drug Metab Rev; 1974; 3(2):185-99. PubMed ID: 4607867
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of route of administration on drug disposition.
    Riegelman S; Rowland M
    J Pharmacokinet Biopharm; 1973 Oct; 1(5):419-34. PubMed ID: 4787618
    [No Abstract]   [Full Text] [Related]  

  • 31. Proceedings: The line-up on bioavailability.
    Schneller GH
    Rev Can Biol; 1973; 32():Suppl:151-5. PubMed ID: 4777598
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pharmacokinetics of digoxin in middle-aged and elderly patients in the subacute period of myocardial infarction].
    Iakovlev SV; Glezer MG; Kholodov LE; Mikhaĭlov AA; Grigor'eva EA
    Kardiologiia; 1986 May; 26(5):33-6. PubMed ID: 3735915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of drug absorption and of drug solution.
    Jollow DJ; Brodie BB
    Pharmacology; 1972; 8(1):21-32. PubMed ID: 4644653
    [No Abstract]   [Full Text] [Related]  

  • 34. Prediction of systemic availability from plasma-level data after oral drug administration.
    Perrier D; Gibaldi M; Boyes RN
    J Pharm Pharmacol; 1973 Mar; 25(3):256-7. PubMed ID: 4146327
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacodynamic and pharmacokinetic measurements in cardiovascular-renal drugs.
    Hayes AH
    Clin Pharmacol Ther; 1974 Jul; 16(1):201-11. PubMed ID: 4843316
    [No Abstract]   [Full Text] [Related]  

  • 36. Oral biopharmaceutics-current status and identified gaps of understanding.
    Lennernäs H; Abrahamsson P; Langguth B
    Eur J Pharm Sci; 2014 Jun; 57():98. PubMed ID: 24508580
    [No Abstract]   [Full Text] [Related]  

  • 37. [Metabolism and pharmacokinetics of lanatosides in man].
    Rietbrock N; Abshagen U
    Dtsch Med Wochenschr; 1973 Jan; 98(3):117-22. PubMed ID: 4684137
    [No Abstract]   [Full Text] [Related]  

  • 38. Bioavailability and digoxin.
    N Z Med J; 1972 Sep; 76(484):203. PubMed ID: 4508750
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacokinetic aspects of drug metabolism.
    Gibaldi M
    Ann N Y Acad Sci; 1971 Jul; 179():19-31. PubMed ID: 4936775
    [No Abstract]   [Full Text] [Related]  

  • 40. Bioavailability of drugs: principles and problems. Report of a WHO Scientific Group.
    World Health Organ Tech Rep Ser; 1973 Nov; 536():1-17. PubMed ID: 4204708
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.